| 國立成功大學 |
2022 |
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
|
Liu, C.J.;Sheen, I.S.;Chen, Chen C.Y.;Chuang, W.L.;Wang, H.Y.;Tseng, K.C.;Chang, T.T.;Yang, J.;Massetto, B.;Suri, V.;Camus, G.;Jiang, D.;Zhang, F.;Gaggar, A.;Hu, T.H.;Hsu, Y.C.;Lo, G.H.;Chu, Chu C.J.;Chen, J.J.;Peng, C.Y.;Chien, R.N.;Chen, P.J. |
| 國立成功大學 |
2022 |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin, C.-L.;Tai, C.-M.;Huang, J.-F.;Liu, C.-J.;Chen, H.-F.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Wang, C.-C.;Weng, S.-H.;Tseng, Tseng T.-C.;Kao, J.-H. |
| 臺大學術典藏 |
2021-12-01T06:03:21Z |
Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: In comparison with ceftazidime treatment
|
Chang S.-C.; Fang C.-T.; Hsueh P.-R.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-12-01T06:03:14Z |
Risk factors for ICU mortality in critically ill patients
|
YEE-CHUN CHEN; Lin S.-F.; Liu C.-J.; Jiang D.D.-S.; Yang P.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:43Z |
Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: In comparison with ceftazidime treatment
|
Chang S.-C.; Fang C.-T.; Hsueh P.-R.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; CHIEN-CHING HUNG; Chen Y.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:42Z |
Bacteremia and fungemia in patients with advanced human immunodeficiency virus (HIV) infection in Taiwan
|
CHIEN-CHING HUNG; Hsueh P.-R.; Hsieh S.-M.; Liu C.-J.; Chen M.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2021-12-01T02:30:34Z |
Amebic liver abscess and human immunodeficiency virus infection: A report of three cases
|
Liu C.-J.; CHIEN-CHING HUNG; Chen M.-Y.; Lai Y.-P.; Chen P.-J.; Huang S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-12-01T02:29:06Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-11-18T04:57:53Z |
Enrichment of human CCR6+ regulatory t cells with superior suppressive activity in oral cancer
|
Lee J.-J; Kao K.-C; Chiu Y.-L; Jung C.-J; Liu C.-J; Cheng S.-J; Chang Y.-L; JENG-YUH KO; Chia J.-S. |
| 臺大學術典藏 |
2021-11-15T07:48:14Z |
Enrichment of human CCR6+ regulatory t cells with superior suppressive activity in oral cancer
|
Lee J.-J; Kao K.-C; Chiu Y.-L; Jung C.-J; Liu C.-J; Cheng S.-J; Chang Y.-L; JENG-YUH KO; Chia J.-S. |
| 臺大學術典藏 |
2021-10-18T06:51:15Z |
Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis
|
Chen T.-Y.; Hsieh Y.-T.; Huang J.-M.; Liu C.-J.; Chuang L.-T.; Huang P.-C.; Kuo T.-Y.; Chia H.-Y.; Chou C.-Y.; Chang C.-W.; Chen Y.-F.; HSIN-MING CHEN; Lo J.-F.; Li W.-C. |
| 臺大學術典藏 |
2021-10-18T06:51:14Z |
Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis
|
Li W.-C.; Huang C.-H.; Hsieh Y.-T.; Chen T.-Y.; Cheng L.-H.; Chen C.-Y.; Liu C.-J.; HSIN-MING CHEN; Huang C.-L.; Lo J.-F.; Chang K.-W. |
| 臺大學術典藏 |
2021-10-18T06:51:14Z |
Corrigendum: Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis (Frontiers in Oncology, (2020), 10, 10.3389/fonc.2020.00176)
|
Li W.-C.; Huang C.-H.; Hsieh Y.-T.; Chen T.-Y.; Cheng L.-H.; Chen C.-Y.; Liu C.-J.; HSIN-MING CHEN; Huang C.-L.; Lo J.-F.; Chang K.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:36Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; Keng L.-T.; Lee M.-R.; JEN-CHANG KO; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; WANG-HUEI SHENG; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-17T05:56:03Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; LI-TA KENG; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T05:41:24Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; KAI-LUN YU; Liu C.-J.; Keng L.-T.; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; SHENG-KAI LIANG; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; Keng L.-T.; Lee M.-R.; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-17T02:50:56Z |
Use of antiplatelet agents and survival of tuberculosis patients: A population-based cohort study
|
MENG-RUI LEE; Lee M.-C.; Chang C.-H.; Liu C.-J.; Chang L.-Y.; Zhang J.-F.; Wang J.-Y.; Lee C.-H. |
| 臺大學術典藏 |
2021-09-17T02:50:56Z |
Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients
|
Huang H.-L.; Liu C.-J.; MENG-RUI LEE; Cheng M.-H.; Lu P.-L.; Wang J.-Y.; Chong I.-W. |
| 臺大學術典藏 |
2021-09-17T02:50:54Z |
Predictors of radiographic progression for NTM–pulmonary disease diagnosed by bronchoscopy
|
Huang H.-L.; MENG-RUI LEE; Liu C.-J.; Cheng M.-H.; Lu P.-L.; Wang J.-Y.; Chong I.-W. |
| 臺大學術典藏 |
2021-09-17T02:50:52Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
Tsou P.-H.; Lin Z.-L.; Pan Y.-C.; Yang H.-C.; Chang C.-J.; Liang S.-K.; Wen Y.-F.; Chang C.-H.; Chang L.-Y.; Yu K.-L.; Liu C.-J.; Keng L.-T.; MENG-RUI LEE; Ko J.-C.; Huang G.-H.; Li Y.-K. |
| 臺大學術典藏 |
2021-09-04T06:24:18Z |
Benign recurrent intrahepatic cholestasis
|
Liu C.-J.; JIA-HORNG KAO; Chen P.-J.; Lai M.-Y.; Mao T.-L.; Wang T.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:24:18Z |
Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus
|
JIA-HORNG KAO; Liu C.-J.; Chen P.-J.; Chen W.; Hsiang S.-C.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:24:13Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu C.-J.; JIA-HORNG KAO; Lai M.-Y.; Chen P.-J.; Chu J.-S.; Chen W.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:20Z |
Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factors
|
Liu C.-J.; JIA-HORNG KAO; Chen W.; Tsai R.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:19Z |
Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:19Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; Chen P.-J.; JIA-HORNG KAO; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:17Z |
Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease
|
Liu C.-J.; JIA-HORNG KAO; Shau W.-Y.; Chen P.-J.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:17Z |
Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B
|
Lin C.-L.; Liao L.-Y.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:15Z |
Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan
|
Liu C.J.; JIA-HORNG KAO; Chen P.J.; Lai M.Y.; Chen D.S. |
| 臺大學術典藏 |
2021-09-04T06:19:15Z |
Hepatitis B viral genotypes and lamivudine resistance [1]
|
JIA-HORNG KAO; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:14Z |
Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study
|
King J.K.; Yeh S.-H.; Lin M.-W.; Liu C.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-04T06:19:13Z |
Molecular Assays for Hepatitis B Virus Infection [1]
|
Liu C.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:12Z |
A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chang C.-F.; Wu H.-L.; Shau W.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:11Z |
Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study
|
Liu C.-J.; Chen P.-J.; Shau W.-Y.; JIA-HORNG KAO; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:11Z |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Jeng Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:09Z |
Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation
|
Liu C.-J.; JIA-HORNG KAO; Wang H.-Y.; Lai M.-Y.; Chen T.-C.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:09Z |
High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users
|
Chen B.-F.; Chen P.-J.; Jow G.-M.; Sablon E.; Liu C.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:19:09Z |
Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users
|
Chen B.-F.; JIA-HORNG KAO; Liu C.-J.; Chen D.-S.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-04T06:19:08Z |
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma
|
Chen J.-D.; Liu C.-J.; Lee P.-H.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:08Z |
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
|
Yeh S.-H.; Tsai C.-Y.; JIA-HORNG KAO; Liu C.-J.; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; Chen D.-S.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-04T06:19:08Z |
Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype Ba
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen T.-C.; Wang H.-Y.; Huang W.-L.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:07Z |
Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis
|
Liu C.-J.; JIA-HORNG KAO; Lai M.-Y.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:07Z |
Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:06Z |
End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B
|
Liu C.-J.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:06Z |
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C
|
Liu C.-J.; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:05Z |
Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan
|
Mah Y.-H.; JIA-HORNG KAO; Liu C.-J.; Chen C.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:04Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; JIA-HORNG KAO; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-09-04T06:19:04Z |
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
|
Liu C.-J.; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
